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a Microvascular Graft in a Low-pressure Situation
Marcus T.C. Wong, Jane Lim and Lim Thiam Chye, Division of Plastic Surgery, Department of Surgery, 
National University Hospital, Singapore.
OBJECTIVE: Microvascular reconstruction is often limited by the availability and length of the pedicle.
The harvesting of autologous vein grafts adds morbidity and may not provide a good match. Expanded
polytetrafluoroethylene (ePTFE) grafts have been used routinely in macrovascular surgery. However, there
are no conclusive data on the performance of small-diameter PTFE grafts for pedicle lengthening in free
flaps in a low-pressure situation. In this study, we evaluated the efficacy of 3-mm diameter stretch ePTFE
grafts to lengthen the venous pedicle of a free flap.
METHODS: Fifteen male New Zealand white rabbits were operated on under sterile conditions. Using an
operating microscope, an epigastric flap was raised and the pedicle was exposed and dissected to its origin
from the superficial femoral vessels. A segment of the vein of 1 cm to 3 cm was replaced with a stretch ePTFE
graft. Microsurgical anastomoses were performed using 9-0 nylon sutures. Four weeks postoperatively, the
flaps were raised again with the pedicles re-explored. The graft was then removed and examined histologically.
RESULTS: All the grafts demonstrated immediate patency. There were no cases of flap loss on the con-
trol side at 4 weeks postoperatively. When re-explored, the patent ePTFE grafts appeared to be covered by
connective tissue. Light microscopy showed neoendothelialization with fibrovascular ingrowth.
CONCLUSION: From this study, we can conclude that 3-mm diameter stretch ePTFE grafts can be used
successfully as an alternative to bridging autologous vein grafts in free-flap pedicles. [Asian J Surg
2007;30(3):188–92]
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Introduction
Following the first successful use of expanded polytetra-
fluoroethylene (ePTFE) grafts to replace the vena cava in an
experimental model,1 these grafts have been routinely used
clinically in macrovascular surgery.2 Compared to early
inconclusive results in terms of patency rates and neointi-
mal growth in experimental models, recent studies have
shown that small-diameter ePTFE arterial grafts can be
expected to reach more than satisfactory results in the
laboratory setting.3–7 This was due mainly to a better
understanding of the effect of the graft’s physical charac-
teristics on patency rates and neoendothelialization,8,9
including capillary ingrowth, the use of endothelial cell
seeding,10 or endothelial growth factors.11
We now have a better understanding of the behaviour of
these grafts in high-pressure situations,12 especially when
they are used as arteriovenous shunts.13–15 The consistent
reliability of these grafts experimentally has led to their
clinical application in a few selected patients.16 However,
there are only limited and somewhat inconclusive data
available as to the performance of small-diameter PTFE
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grafts as an alternative to bridging autologous vein grafts
in free-flap pedicles.15,17 In addition, there are no studies
for venous pedicle lengthening. Stretch expanded PTFE
became available for clinical usage in 1991. Since then, its
use in haemodialysis access surgery18 and femoropopliteal
bypass surgery19 has demonstrated a significant advantage
over the standard ePTFE graft. In this study, we evaluated
the efficacy of 3-mm diameter stretch ePTFE grafts 
to lengthen the venous pedicle of a free flap in a low-
pressure situation. The viability of a rat epigastric free
flap has been described as a good indicator of graft patency
for evaluation of small diameter grafts.20 We selected a
well established and reliable flap, the rabbit epigastric
flap because thrombogenically, the rabbit resembles the
human more closely than does the rat.21 In our study, we
explored the use of stretch ePTFE as a synthetic microvas-
cular graft in a venous low-pressure situation in compari-
son to native vein grafts.
Materials and methods
Approval and consent for this study were obtained from
our institutional animal care and use committee (IACUC).
A total of 15 male New Zealand white rabbits, weighing
between 2,500 and 3,500 g were induced with intramus-
cular ketamine hydrochloride (35 mg/kg) and xylazine
(5 mg/kg), and operated on under sterile conditions and
general anaesthesia with a halothane/oxygen mixture
(2.5% at 2 L/min to maintain anaesthesia) using a standard
anaesthetic machine. After shaving and prepping, bilateral
epigastric flaps measuring 2 × 2 cm were outlined on the
rabbit’s lower abdomen.
Using an operating microscope, the flaps were raised
and the pedicle on each side consisting of the inferior
superficial epigastric artery and vein was exposed and dis-
sected to its origin from the superficial femoral vessels.
The superficial femoral artery and vein were freed proxi-
mally and distally to the flap pedicle. Single microvascular
clamps were positioned proximally and distally on the left
superficial femoral artery and vein. These vessels were lig-
ated and transected distal to the epigastric branches.
Finally, the superficial femoral vein was transected proxi-
mally and reconstituted with an intervening length of
25 µm fibril stretch ePTFE with an internal diameter of
3 mm and a wall thickness of 0.18 mm.
Similarly, on the control side, a segment of autologous
vein graft of the same length as the contralateral ePTFE
side was harvested and anastomosed in its original position.
Prior to anastomosis, measurements of vein diameter
after dilation were taken using the markings on the Biemer
microclip under the operating microscope. Anastomosis
was performed proximally and distally with 9-0 nylon inter-
rupted sutures. Once the anastomoses were completed,
the clamps were released and flap reperfusion was observed.
The milking test was carried out to evaluate patency of the
synthetic and autologous vein. The skin portion was then
closed bilaterally with 5-0 prolene running sutures. All
flaps were then covered with OpSite spray to help prevent
self-mutilation.
The animals were housed in single cages and fed a nor-
mal diet. Antibiotics (cephalexin 500 mg/day) were admin-
istered in the drinking water postoperatively for 7 days.
Flaps were checked for signs of ischaemia and/or venous
congestion or infection. No intraoperative pharmacological
agents such as papaverine or lignocaine were administered.
Postoperatively, there was also no use of antithrombotics
such as dextran or low molecular weight heparin.
At 4 weeks post procedure, the animals were anaes-
thetized using the same procedure. The flaps were raised
again and the pedicles explored. A milking test was carried
out to evaluate patency of the left synthetic vein and the
right control vein. The superficial femoral artery was then
clamped and the flap flushed with saline and fixative (5%
glutaraldehyde buffered to pH 7.4) through the artery. The
graft was then removed and prepared for histological eval-
uation. All harvested grafts including the anastomotic
sites were cut transversely, stained with haematoxylin and
eosin (H&E) and examined under light microscopy.
Statistical analysis was performed using Fisher’s exact
test to compare patency between different groups. This test
was applied to study the patency or flap vitality among
the different graft lengths of 1, 2 and 3 cm and also the
difference in immediate patency, 4-week patency, partial
necrosis or complete flap loss between the control group
and the ePTFE group collectively. Statistical significance
was defined as p < 0.05.
Results
Mean body length of the animals was 65 cm. Mean vein
diameter was 2.1 mm (median, 2.0 mm; range, 1.8–2.3 mm)
(Figure). Immediate patency and 4-week patency was pres-
ent for all the pedicles on the control side. All but two of
the control flaps were vital. These two flaps demonstrated
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partial necrosis with granulation tissue formation at 
4 weeks. None of the control flaps demonstrated any evi-
dence of infection and all of the veins were patent at 4 weeks
even with the control flaps that showed partial necrosis.
On the study side, 12 out of 15 of the flaps were vital
with good hair growth. None of these flaps demonstrated
necrosis or infection. When re-explored, all the grafts were
patent with evidence of macroscopic fibrovascular integra-
tion externally. When cut open, the grafts did not demon-
strate any intraluminal thrombi.
Histologically, the patent grafts were lined with neoin-
tima, but to varying extents. At the proximal and distal
ends, there was a monolayer of endothelium with a mul-
tilayered subendothelium. There was an outer covering of
neoadventitia in all the grafts which consisted of mature
connective tissue with a wide spread of capillary blood ves-
sels. However, none of the capillaries penetrated the inner
surface of the grafts. Also, there was a scarcity of cellular
infiltration of the graft wall.
In two of the study flaps, there was evidence of partial
necrosis with hair loss, granulation tissue and slough for-
mation. The grafts in these flaps were found to be occluded
both clinically and histologically. The lumens of these two
grafts were filled with connective tissue with no evidence
of recanalization. There was still, however, fibrovascular
integration externally with capillary and mature connective
tissue formation.
There was one case of complete flap loss in the 3 cm
group with complete replacement of the skin paddle by
slough and granulation tissue. There was no evidence of
hair growth on this flap. On dissection of the pedicle,
there was no flow proximally or distally. Histologically, the
entire lumen was occluded by fibrous connective tissue.
There was no statistically significant difference in
patency or flap vitality among the different graft lengths
of 1, 2 and 3 cm (Table 1). There was also no statistically
significant difference in immediate patency, 4-week patency,
partial necrosis or complete flap loss between the control
group and the ePTFE group collectively (Table 2).
Discussion
From the work previously performed in our unit, we note
that the rat epigastric flap is a good indicator of graft
patency.22 However, thrombogenically, the rabbit resembles
human more closely than rat.21 This formed the basis for our
choice of the rabbit epigastric free flap in this animal exper-
imental model. Materials for synthetic microvascular grafts
that have been investigated include polytetrafluoroethylene,
silicone, bovine collagen, denatured human umbilical arter-
ies, Teflon, polyurethane and other polyesters.23 The largest
number of experimental studies have been carried out
using different types of PTFE prostheses.
Previous studies have had variable results with PTFE
in a microvascular arterial situation. Patency ranged from
Table 1. Comparison of patency and flap viability for various graft lengths
Control 1 cm 2 cm 3 cm
Immediate patency 15 5 5 5
4-week patency 15 5* 3* 4*
Partial necrosis 2 0* 1* 1*
Flap loss 0 0* 1* 0*
Thrombosis 0 0* 2* 1*
Neoendothelialization NA 5 3 4
*Not statistically significant.
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Figure. Diameter of superficial femoral vein (SFV) prior to anas-
tomosis in 15 animals on study side.
0% to 100% in those studies.4,17 This study, we believe, is
the first animal study using stretch ePTFE to focus on a
microvascular venous or low-pressure situation. As control,
we used the contralateral flap with replacement of the
superficial femoral vein with autologous vein graft from
the same site. This excludes the confounding factors of
finding a matching autologous vein graft and technical
aspects of anastomosis. The patency rate beyond 4 weeks
was not studied as the free flap receives additional supply
from the surrounding tissues. After this period, the 
pedicle can theoretically clot or be safely ligated without
compromising flap viability.16
We note that in our study, there is a discrepancy
between native vein and stretch ePTFE graft diameter with
stretch ePTFE having a larger diameter. This discrepancy
has not always led to turbulence and thrombosis in our
study. We believe that this improved patency is due to the
rigidity of the material which acts as a microvascular splint
maintaining patency of the grafts. This is also based on
fluid dynamics with Poiseuille’s equation24 giving rise to
increased flow with a larger vessel or graft diameter. This,
combined with Bernoulli’s equation,24 creates a situation
with high flow and low pressure. The increased pressure
differential improves venous drainage from the flap and
patency of the graft.
There appears to be no correlation between graft length
and patency in our study up to 3 cm. The number of ani-
mals studied was small, especially for the subgroup analy-
sis, hence the use of Fisher’s exact test which is designed
to be used when the cell number is less than five as opposed
to the χ2 test. There was also no statistically significant
difference between the various lengths of 1, 2 and 3 cm in
terms of flap vitality. When compared to the control side,
there was no statistically significant difference in terms
of patency and flap vitality for the different lengths. This
sets up stretch ePTFE graft as a possible alternative to
native vein graft in a microvascular setting using 3 mm
internal diameter grafts.
There is integration of the stretch ePTFE graft as evi-
denced by neoendothelialization on the luminal aspect of
patent grafts and formation of neoadventitia on the exter-
nal aspect of all grafts. This neoadventitia is made up of
mature connective tissue and capillary formation.
This has potential applications in pedicle lengthening,
venous superdrainage25 and bridging microvascular grafts.
It may also represent a paradigm shift in thinking related
to flaps and possibly ischaemic limb management. The
traditional focus is on arterial inflow. Improving venous
drainage and flow through a flap or limb may contribute
significantly, if not more, to flap and limb viability.
In conclusion, there was no statistically significant
difference in immediate patency, 4-week patency and flap
vitality between 3-mm diameter stretch ePTFE graft and
native vein graft. Stretch ePTFE is well integrated into the
rabbit model with neoendothelialization and neoadventitia
formation in patent grafts.
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